Pneumococcal Vaccines Market Is Driven by Increasing Immunization Programs

Global pneumococcal vaccines market is estimated to be valued at USD 9.38 billion in 2025 and is expected to reach USD 13.29 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.1% from 2025 to 2032.

Pneumococcal Vaccines Market - https://cmi.hashnode.dev/p...

#PneumococcalVaccinesMarketSize #PneumococcalDisease
#CoherentMarketInsights #VaccineMarketGrowth #GlobalVaccineMarketExpansion

Pneumococcal Vaccines Market is Anticipated to Witness High Growth Owing to Increasing Government Initiatives

The pneumococcal vaccines market involves vaccines that help prevent pneumococcal disease. Pneumococcal disease refers to illnesses caused by the bacterium Streptococcus pneumoniae, including pneumonia, meningitis, and bacteremia. There are two main types of pneumococcal vaccines: pneumococcal conjugate vaccine (PCV) and pneumococcal polysaccharide vaccine (PPSV). PCV is recommended for children younger than 2 years, while PPSV is recommended for adults 65 years or older.

Get More Insights on Pneumococcal Vaccines Market
https://articlescad.com/pn...

#PneumococcalVaccinesMarketSize #PneumococcalDisease
#CoherentMarketInsights #VaccineMarketGrowth #GlobalVaccineMarketExpansion